Yasushi Iida
Koshigaya, 3438555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination-deficient gynecologic large-cell neuroendocrine carcinoma: A case report.
Journal: Gynecologic oncology reports
Published: April 09, 2026
Impact of obesity on perioperative outcomes in robot-assisted surgery for endometrial cancer: A single-center study of 119 cases.
Journal: European journal of obstetrics & gynecology and reproductive biology: X
Published: January 11, 2026
A rare case of uterine carcinosarcoma in a 21-year-old woman with hereditary breast and ovarian cancer syndrome: A case report.
Journal: Oncology letters
Published: July 11, 2025
Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma.
Journal: Gynecologic oncology
Published: April 01, 2025
Primary carcinosarcoma of the uterine cervix with somatic mutations of the ATM and NF2 genes: a case report.
Journal: International cancer conference journal
Published: November 11, 2024
Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway.
Journal: Frontiers in oncology
Published: September 27, 2023
Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway.
Journal: Gynecologic oncology
Published: June 10, 2022
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2022
Clinical Availability of Tumour Biopsy Using Diagnostic Laparoscopy for Advanced Ovarian Cancer.
Journal: In vivo (Athens, Greece)
Published: July 25, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma.
Journal: The Journal of pathology
Published: March 28, 2021
Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma.
Journal: Scientific reports
Published: December 03, 2020
Last Updated: 09/26/2026